Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) — Balance sheet
Assets, liabilities, and shareholders' equity for Saudi Pharmaceutical Industries and Medical Appliances Corporation — annual and quarterly history.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | 204↑67.1% | 122↓23.8% | 160↓52.3% | 335↑2.1% | 328 | |
| Short-Term Investments | 180↑16.1% | 155↑34.1% | 116↑155.3% | 45↓92.0% | 568 | |
| Cash & Short-Term Investments | 384↑38.5% | 278↑0.6% | 276↓27.5% | 381↓57.5% | 896 | |
| Net Receivables | 1,260↑5.7% | 1,191↑28.9% | 924↑2.0% | 906↓15.0% | 1,066 | |
| Accounts Receivable | 1,183↑0.6% | 1,175↑32.6% | 886↑21.8% | 727↓22.8% | 942 | |
| Other Receivables | 77↑368.5% | 16↓60.8% | 42↓76.6% | 179↑44.0% | 124 | |
| Inventory | 696↑7.8% | 646↓5.9% | 686↑38.7% | 495↑18.0% | 419 | |
| Prepaid Assets | 21 | 0.00↓100.0% | 23↓3.2% | 24↓69.0% | 77 | |
| Other Current Assets | 14↓94.4% | 257↑678.9% | 33↑161.9% | 13↑174.5% | 5 | |
| Total Current Assets | 2,376↑0.9% | 2,356↑19.3% | 1,975↑5.0% | 1,881↓23.6% | 2,462 | |
| Property, Plant & Equipment | 1,784↑2.2% | 1,746↓5.0% | 1,838↑0.5% | 1,829↑0.6% | 1,818 | |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Intangible Assets | 104↓17.1% | 126↑89.4% | 66↑28.4% | 52↓27.7% | 71 | |
| Goodwill & Intangible Assets | 104↓17.1% | 126↑89.4% | 66↑28.4% | 52↓27.7% | 71 | |
| Long-Term Investments | 81↑20.2% | 68↑217.2% | -58↓5324.8% | 1↑100.2% | -504 | |
| Tax Assets | 22↑4.0% | 21↓25.2% | 29↑21.8% | 23↑24.0% | 19 | |
| Other Non-Current Assets | 0.00↓100.0% | 2↓98.7% | 174↑282.0% | 45↓92.0% | 568 | |
| Total Non-Current Assets | 1,992↑1.5% | 1,963↓4.2% | 2,049↑5.0% | 1,951↓1.1% | 1,972 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Assets | 4,368↑1.1% | 4,319↑7.3% | 4,024↑5.0% | 3,832↓13.6% | 4,434 | |
| Liabilities | ||||||
| Total Payables | 595↑4.7% | 568↑48.7% | 382↑49.1% | 256↓52.5% | 539 | |
| Accounts Payable | 374↓16.3% | 446↑33.8% | 333↑49.5% | 223↓26.6% | 304 | |
| Other Payables | 221↑81.6% | 122↑151.2% | 48↑46.2% | 33↓85.9% | 236 | |
| Accrued Expenses | 58 | 0.00↓100.0% | 53↓48.8% | 104 | 0.00 | |
| Short-Term Debt | 967↓6.9% | 1,039↑97.7% | 525↓22.4% | 677↓20.6% | 853 | |
| Current Lease Obligations | 0.00↓100.0% | 3↓57.8% | 7↑17.3% | 6↓15.3% | 7 | |
| Tax Payables | 0.00↓100.0% | 63↑24.3% | 51↑1102.3% | 4↑43.5% | 3 | |
| Deferred Revenue | 176 | 0.00↓100.0% | 125↑176.5% | 45↓90.1% | 460 | |
| Other Current Liabilities | 64↓84.0% | 400↑28.6% | 311↑19.6% | 260↑8.2% | 241 | |
| Total Current Liabilities | 1,860↓7.5% | 2,010↑43.1% | 1,405↑4.1% | 1,349↓17.7% | 1,640 | |
| Long-Term Debt | 462↑0.0% | 462↓19.7% | 575↑51.5% | 380↓8.9% | 417 | |
| Non-Current Lease Obligations | 5↓41.0% | 8↓25.9% | 11↓39.9% | 19↑6.3% | 18 | |
| Non-Current Deferred Revenue | 52↓38.9% | 85↑3.5% | 82↑5.1% | 78↑11.0% | 70 | |
| Deferred Tax Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Liabilities | 187↓15.8% | 222↓21.4% | 283↓27.7% | 391↑6.8% | 366 | |
| Total Non-Current Liabilities | 706↓9.2% | 778↓18.2% | 951↑20.4% | 790↓1.4% | 801 | |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Lease Obligations | 5↓56.7% | 11↓38.3% | 19↓25.8% | 25↑0.0% | 25 | |
| Total Liabilities | 2,566↓8.0% | 2,788↑18.3% | 2,356↑10.2% | 2,139↓12.4% | 2,441 | |
| Equity | ||||||
| Treasury Stock | -20↑0.3% | -20↓149.9% | -8 | 0.00 | 0.00 | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock | 1,200↑0.0% | 1,200↑0.0% | 1,200↑0.0% | 1,200↑0.0% | 1,200 | |
| Retained Earnings | 79↑166.1% | -120↓2905.3% | -4↑97.8% | -179↓271.7% | 104 | |
| Additional Paid-In Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Accumulated Other Comprehensive Income | 337 | 0.00 | 0.00↓100.0% | 519↓2.8% | 533 | |
| Other Stockholders' Equity | 0.00↓100.0% | 318↓0.1% | 319 | 0.00 | 0.00 | |
| Total Stockholders' Equity | 1,597↑15.9% | 1,378↓8.5% | 1,507↓2.1% | 1,540↓16.2% | 1,838 | |
| Total Equity | 1,762↑15.1% | 1,531↓8.2% | 1,668↓1.5% | 1,693↓15.1% | 1,993 | |
| Minority Interest | 166↑8.2% | 153↓5.2% | 161↑5.1% | 154↓1.3% | 156 | |
| Total Liabilities & Equity | 4,368↑1.1% | 4,319↑7.3% | 4,024↑5.0% | 3,832↓13.6% | 4,434 | |
| Balance Sheet Summary | ||||||
| Total Investments | 262↑17.6% | 223↑282.8% | 58↑25.1% | 47↓26.5% | 63 | |
| Total Debt | 1,434↓4.4% | 1,501↑34.1% | 1,119↑3.5% | 1,082↓16.5% | 1,295 | |
| Net Debt | 1,230↓10.8% | 1,379↑43.8% | 959↑28.5% | 746↓22.8% | 966 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.